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Abstract 
Adenoid cystic carcinoma (ACC) is a malignant salivary gland tumor, which shows 
frequent recurrence and metastasis, ultimately with a poor outcome.  We previously 
demonstrated that p27 down-regulation is frequently found and is due to an enhancement 
of its degradation in ACC.  Here we transfected non-degradable p27 mutant (T187A) and 
wild type gene into ACC cell line.  Transfection of T187A mutant gene was more effective 
on inhibition of cell growth of ACC cells, suggesting that aberration of p27 degradation 
may be present in ACC.  As F-box protein Skp2, which is necessary for ubiquitin-mediated 
degradation of p27, is involved in p27 down-regulation in various cancers, we examined 
the Skp2 expression and its correlation with p27 expression in 50 ACC cases.  We found 
Skp2 expression in 36% of ACC cases and inverse correlation between the expression of 
Skp2 and p27.  Moreover, Skp2 siRNA transfection decreased Skp2 protein and 
accumulation of p27 protein and inhibited the cell growth of ACC cells in vitro.  These 
findings overall suggest that Skp2 may play an important role in ACC development 
through the down-regulation of p27, and that Skp2 siRNA can be a novel modality of 
cancer gene therapy for suppression of p27 down-regulation in ACC. 
 
Key words: Adenoid cystic carcinoma; Skp2; p27; proliferation; salivary gland 
Abbreviations: ACC, adenoid cystic carcinoma; Skp2, S-phase kinase-associated protein 
2; TGF- ß, transforming growth factor-beta; siRNA, small interfering RNA: Cul1, cullin1; 
PCNA, Proliferating Cell Nuclear Antigen Jab1, Jun activation domain-binding protein-1; 
KPC, Kip1 ubiquitination-promoting complex. 
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Introduction 
Adenoid cystic carcinoma (ACC) is one of the most common malignant tumors of major 
and minor salivary glands [4,23,31,33,36].  Although ACC tends to grow slowly, this 
neoplasm has a poor prognosis in comparison with the majority of other malignant salivary 
gland tumors [23,31].  ACC shows various histological patterns such as cribriform, tubular 
and solid.  It is generally regarded that tubular or cribriform pattern dominant subtypes 
have much better prognosis than those with predominantly solid patterns [5-7].  However, 
it is often difficult to predict the prognosis of ACC by histological findings alone, especially 
when dealing with inadequate biopsy material [23,41].  Thus, there is a need to explore 
additional parameters for predicting the prognosis of ACC.  Previous our study 
demonstrated that cyclin-dependent kinase inhibitor, p27 was frequently down-regulated 
and well correlated with its malignant behavior in ACC [34].  p27 mediates G1 arrest 
induced by TGF- ß, contact inhibition, or serum deprivation in epithelial cell lines [25,38].  
The increase in the cellular abundance of p27 upon induction of cell quiescence is 
primarily due to a decrease in the rate of its degradation [22].  p27 is poly-ubiquitinated 
both in vivo and in vitro and a lower amount of p27 ubiquitinating activity is present in 
proliferating cells compared to quiescent cells [22].  Furthermore, p27 ubiquitination 
requires its phosphorylation on threonine 187 (T187) [19].  Down-regulation of p27 was 
frequently found in various cancers, and the lack of p27 is suggested to be due to an 
enhancement of its degradation [30].  Aggressive human cancers express low levels of 
p27 because of its decreased stability [30].  Importantly, reduced p27 levels represent a 
powerful prognostic marker for poor survival in cancer patients.   
 Skp2 was originally identified as a protein that interacts with cyclin A [43].  It has been 
reported that p27 is specifically recognized and targeted for ubiquitination by Skp2 [1.32.39].  
Skp2 is required for the ubiquitination and consequent degradation of p27 both in vivo and in 
vitro [1.32.39].  Skp2 is a rate-limiting component of the machinery that ubiquitinates and 
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degrades phosphorylated p27 [1].  Skp2 is frequently overexpressed in tumor cell lines, and 
forced expression of Skp2 in quiescent fibroblasts induces DNA synthesis [32,43].  Recently, 
it has been revealed that Skp2 overexpression is frequently found and is well correlated with 
down-regulation of p27 protein in various types of cancer [15.39].  
 In the present study, we transfected non-degradable mutant and wild type p27 into 
ACC cell line.  Moreover, we examined the immunohistochemical expression of Skp2 and 
its correlation with p27 expression.  Finally, we examined if siRNA-mediated gene 
silencing of Skp2 can be employed in order to inhibit p27 down-regulation in ACC. 
 
Materials and methods 
All procedures of the present studies were performed in compliance with regulations 
administered by the Hiroshima University. 
 
Cell culture 
We used ACCh cell line that was established in the Department of Oral Maxillofacial 
Surgery, Hiroshima University School of Dentistry (kindly provided by T. Okamoto), and 
was maintained in 5 % CO2, 95 % air at 37 ˚C.  ACCh cells were maintained in serum-free 
RD153 medium (RPMI1640:DMEM:MCDB153;1:1:2, v/v/v) containing 10 mg/ml insulin, 
10 mM 2-mercaptoethanol, 10 mM 2-aminoethanol and 10 nM selenite [20,26,28].  For 
experiments, these cells were grown to sub-confluence in each medium. 
 
Generation of stable clones expressing inducible p27  
For stably expressing p27 wild type and mutant in an inducible way, we used an 
ecdysone-inducible mammalian expression system (Invitrogen, Carlsbad, CA) as we 
described previously [14].  To construct pIND-p27 (wild type; WT) or pIND-p27 
(threonine-to-alanine p27 mutant; T187A), a Bam HI/Eco RI fragment was isolated 
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from pcDNA3-p27 WT or pcDNA3-p27 T187A (kindly provided by M. Pagano), and 
cloned into pIND ecdysone-inducible expression vector (Invitrogen) digested with Bam 
HI/Eco RI.  Transfection was performed in 60 mm plates using 2 μg of expression 
vector by using Fugene 6 (Roche).  ACCh cells stably expressing ecdysone receptor 
(EcR) were first isolated with Zeocin (Invitrogen) as a selective marker.  The EcR cells 
were then used to generate clones that incorporated ecdysone response elements 
followed by wild type and T187A mutant p27 with G418 (Life Technologies, Inc.) as a 
selective marker.  Cells were treated with ponasterone A (5 μM) for 24, 48 and 72 hour 
for induction of p27 expression. 
 
Western blot analysis   
We examined the expression of p27, Skp2 and Cul1 proteins in ACC cell lines by Western 
blot analysis.  Western blotting was carried out as we described previously [13].  We used an 
anti-p27 mouse monoclonal antibody (Transduction Laboratories), anti-Skp2 monoclonal 
antibody (Zymed laboratories Inc.) and an anti-Cul1 polyclonal antibody (Zymed laboratories 
Inc.).  Thirty μg of protein was subjected to 10 % polyacrylamide gel electrophoresis followed 
by electroblotting onto a nitrocellulose filter.  For detection of the immunocomplex, the ECL 
western blotting detection system (Amersham, Aylesbury, UK) was used. 
 
Tissue samples 
Fifty ACCs including 7 cases with metastasis were retrieved from the pathological files of 
Hiroshima University Hospital (Japan), Peradeniya University (Sri Lanka) and Sichuan 
University (China).  Clinical data of the patients are summarized in Table 1.  Among the 50 
ACC patients, 20 were males and 30 were females.  At the time of diagnosis their age 
ranged from 30 to 84 years (average; 59.7?15.1).  The tumors were subclassified 
according to the histological grading of Szanto et al. as follows: Grade I, tumors with 
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cribriform and/or tubular structures without a solid component; Grade II, tumors composed 
of cribriform and/or tubular structures with less than 30% of solid areas; and Grade III, 
tumors with more than 30% of solid areas [33]. 
 
Immunohistochemistry 
Immunohistochemical detection of Skp2, p27 and PCNA was performed using a 
streptavidin-biotin peroxidase technique as described previously [13,34].  An anti-human 
Skp2 mouse monoclonal antibody (dilution 1:100, Zymed laboratories Inc., San Francisco, 
CA), an anti-human p27 mouse monoclonal antibody (dilution 1:100, Transduction 
Laboratories, Lexington, KY) and an anti-human PCNA antibody were used.  Nuclear 
staining of Skp2, p27 and PCNA was scored on a semi-quantitative scale (see below) by 
evaluating the percentage of stained nuclei within representative areas of each tumor.  
For small or superficial carcinomas, stained sections were observed throughout the lesion.  
For advanced large tumors, at least ten fields (including superficial, central and deep 
invasive areas) were observed and the number of stained cells and staining intensity were 
evaluated.  The expression of Skp2 was graded as + (over 5 % of tumor cells showed 
strong or diffuse immunopositivity) and - (less than 5 % of the tumor cells showed weak or 
focal immunopositivity or no staining).  The expression of p27 was graded as described 
previously [34].  A labeling index, percentage of nuclear stained cells, of PCNA was 
determined by the examination of at least 500 cells in three representative and intensely 
stained areas.  PCNA labeling index was graded as I (less than 25 % of cells are positive), 
II (25-50% of cells are positive) and III (over 50% of cells are positive).  Three observers (I. 
O., Y. K. and S. S.) made independent assessments of the immunohistochemical grading 
of Skp2, p27 and PCNA and where the gradings were divergent an agreement was 
reached following discussion.   
 
                                                                                                               Keikhaee et al. 7 
Statistical Analysis 
Possible correlation between variables of the analyzed tumor samples was confirmed by 
the Fisher's exact test.  A P value < 0.05 was required for significance.   
 
Plasmids and synthetic siRNA   
Vector pSuppressorNeo generates biologically active siRNAs from the U6 promoter 
(Imgenex, San Diego, CA).   Synthetic two oligonucleotides primers(5’-tcgaGGGAGUG 
ACAAAGACUUUGgaguacugCAAAGUCUUUGUCACUCCCUUUUU-3’and 5’-ctagAAA 
AAGGGAGUGACAAAGACUUUGcaguacucCAAAGUCUUUGUCACUCCC-3’) containing 
Xho I and Xba I overhangs were annealed and then were introduced into 
pSuppressorNeo vector.  Oligonucleotide sequences correspond to a 19-nt sequence 
from Skp2 (nucleotide 114-133), which are separated by an 8-nt linker (lower case letters) 
from the reverse complement of the same 19-nt sequence.  We also added transcriptional 
termination (UUUUU) to the end of oligonucleotide.  We used circular control plasmid, 
which contains a scrambled sequence that does not show significant homology to rat, 
mouse or human gene sequences, as a control.  Transfection was performed in 60 mm 
plates using 2 μg of vector and 10 μl of Fugene 6 reagent (Roche).  After 48 hours of 
transfection, cells were treated G418 (Gibco) for 2 weeks as a selective marker.  After 
G418 treatment, we obtained stably transfectant cells.   
 
Results 
Non-degradable p27 mutant more effectively inhibit cell growth of ACC cells in 
comparison with wild type 
 In our previous study, frequent reduced expression of p27 was observed and well 
correlated with its malignant behavior in ACC [34].  We also found a high p27 
degradation activity in ACCh cells, which did not express p27 protein [34].  Therefore, in 
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the present study, we transfected ACCh cells with p27 T187A mutant gene, which is not 
influenced by ubiquitin-mediated degradation, and p27 WT gene in an inducible way.  
These cells were first transfected with a Drosophia EcR, then with the p27 WT or T187A 
mutant gene that was placed under the control of the ecdysone-inducible promoter 
element such that expression of the p27 transgenes could be regulated with the 
ecdysone analog ponasterone A.  Ponasterone A induced overexpression p27 WT and 
T187A mutant proteins at 72 and 24 h, respectively (Fig. 1A and B).  We next determined 
the effects of p27 transfection on cell growth.  The induction of T187A mutant protein by 
ponasterone A inhibited cell growth in ACCh cells (Fig. 1A and B).  The growth-inhibitory 
effect in WT induction was lower than that in T187A mutant.  Our previous study showed 
that WT p27 was more stable than T187A mutant [14].  Therefore, we think that 
exogenous WT was induced later than T187A.  Similarly to other types of cancer, 
aberrant regulation of p27 protein degradation may play an important role for down-
regulation of p27 protein in ACC. 
 
Immunohistochemical expression of Skp2 and p27 in ACC 
p27 is specifically recognized and targeted for ubiquitination by Skp2 [1,32,39].  It has 
been reported that Skp2 overexpression is found and is well correlated with p27 down-
regulation in various types of malignant tumors [3,8,9,13,16,18,29,42].  Here, therefore, 
we examined the expression of Skp2 and its correlation with p27 expression in 50 ACC 
cases.  Table 1 summarizes the clinical and immunohistochemical results of 50 patients.  
In brief, there were 30 females and 20 male patients and the age ranges from 30-84 
years.  Palate was the commonest site.  Out of 50 cases, Skp2 expression was found in 
18 (36%) cases.  Then, Skp2 expression was compared with p27 expression, PCNA 
labeling index and clinico-pathological parameters including histology and metastasis as 
summarized in Table 2.  Reduced expression of p27 was found in 38 (76%) cases in 
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similar to our previous report [34].  Interestingly, Skp2 expression was inversely 
correlated with p27 expression (P=0.00519) (Fig 2A-D and Table 2).  Furthermore, Skp2 
expression was statistically correlated with high proliferative activity (PCNA index) 
(P=0.000311) (Table 2).  However, Skp2 expression was not correlated with histological 
grading and lymph node metastasis (Table 2).  
 
Skp2 siRNA induced p27 accumulation and inhibited the cell proliferation in ACC cells   
Next, to suppress the ubiquitin-mediated degradation of p27 which frequently shown in ACC, 
we inhibited Skp2 expression by siRNA in ACCh cells.  ACCh cells showed high expression 
of Skp2 and down-regulation of p27 (Fig. 3A).  In order to block Skp2 expression selectively 
by siRNA, 19-nt target sequence, separated by an 8-nt spacer from its reverse complement 
sequence, was introduced into the siRNA generating pSuppressorNeo vector system.  Skp2 
siRNA was transfected into ACCh cells.  After selection using G418, we could get stable 
clones of Skp2 siRNA.  Skp2 siRNA transfection induced the down-regulation of Skp2 protein 
(Fig. 3A).  As we expected, accumulation of p27 protein was observed in Skp2 siRNA 
transfectant cells.  Next, we examined the effect of Skp2 siRNA transfection on cell 
proliferation.  Skp2 siRNA transfectant cells grew in vitro slower than control siRNA 
transfectant cells (Fig. 3B). 
 
Discussion 
ACC, which is one of the most common malignant tumors of major and minor salivary 
glands, typically presents an indolent and slow growth associated to frequent late distant 
metastases, which are together with local recurrences, the reasons for the low long-term 
survival rate [4,23,31,33,36,40].  Standard treatment has not yet been established, 
although many series of ACC have been described.  Several studies showed that 
advanced clinical stage and solid histological subtype are relevant prognostic factors 
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associated with survival of the patients [12,21].  However, it is often difficult to predict the 
prognosis of ACC by histological findings alone, especially when dealing with inadequate 
biopsy material [23,41].  Thus, there is a need to explore additional parameters for 
predicting the prognosis of ACC.   
The proliferation and progression of cancer cells may be caused by abnormalities 
of various positive and negative cell cycle regulators [10,27].  Recently, reduced 
expression of p27 was found in various cancers, and was correlated to their malignancy 
and poor prognosis [13].  Our previous study showed that reduced expression of p27 was 
observed in 83 % of ACCs and was well correlated with metastasis [34].  These findings 
suggest that the reduction of p27 protein may be involved in the development of ACC and 
might be a prognostic marker for ACC patients.  Moreover, we found that p27 protein was 
accumulated by proteasome inhibitor treatment in ACC cell line, ACCh cells which 
showed reduced expression of p27 protein [34].   In addition, here we demonstrated that 
exogenous non-degradable p27 mutant was more rapidly induced and more effective for 
inhibition of cell growth in comparison with wild type p27 by using inducible way in ACC 
cells (Fig. 1).  Therefore, we strongly suggest that p27 down-regulation found in ACC 
might be caused by increased degradation of p27 protein.  This hypothesis is supported 
by previous findings that aggressive human cancers such as colon cancers, lymphomas 
and astrocytic brain tumors express low levels of p27 because of its decreased stability 
[2,17,24,35].   
Recently, SCFSkp2 was identified as the E3 ubiquitin ligase that targets p27 for 
ubiquitination [1,32,39].  Importantly, Skp2 is frequently overexpressed in tumor cell lines, 
and forced expression of Skp2 in quiescent fibroblasts induces DNA synthesis [43].  In 
fact, here we found that Skp2 expression was inversely correlated with p27 expression in 
ACC cases.  This is the first report on Skp2 expression in salivary gland tumor.  It has 
been reported that Skp2 overexpression is found in other types of malignant tumor 
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including lymphomas, oral cancers, breast cancers, colon cancers, lung cancers and 
gastric cancers [3,8,913,16,18,29,42].  Therefore, we suggest that p27 down-regulation 
mediated by Skp2 overexpression may be a common event in various cancers.  
Previously, we reported that reduced expression of p27 was well correlated with 
metastasis in ACC [34].  In the present study, we also found similar relationship; 5 of 7 
(71%) cases with metastasis showed reduced expression of p27, while 22 of 43 (51%) 
cases without metastasis showed reduced expression of p27 (data not shown).  However, 
we could not find possible correlation between Skp2 expression and metastasis.  This 
discrepancy may be accounted for by other pathway of p27 degradation such as Jab1, 
KPC and so on [11,37].  To clarify the detailed mechanism of p27 degradation in cancer, 
further studies are required.  Although it is generally regarded that tubular or cribriform 
pattern dominant subtypes have much better prognosis than those with predominantly 
solid patterns [5-7], we could not find the correlation between Skp2 expression and 
histological grading.  Interestingly, Skp2 expression was well correlated with PCNA.  This 
data was confirmed by the finding that Skp2 knockdown by using siRNA transfection 
inhibited cell growth through accumulation of p27 protein in ACC cells (Fig. 2).  We 
suggest that Skp2 overexpression may be involved in growth of ACC cells through p27 
protein degradation, and that Skp2 siRNA can be a therapeutic target for ACC patients.   
In conclusion, we showed that Skp2 expression is strongly correlated with p27 
down-regulation and cell proliferation in ACC.  Our findings are in agreement with those 
reported previously and provide evidence for the p27-degradative function of Skp2 in ACC.
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Figure legend 
Fig. 1. Transfection of p27 WT gene and T187A mutant gene into ACCh cells.  For stably 
expressing p27 WT and mutant in an inducible way, we used ecdysone-inducible 
mammalian expression system by the provided protocol (Invitrogen).  ACCh cells stably 
expressing EcR were first isolated with Zeocin.  The EcR cells were then used to generate 
clones that incorporated ecdysone response elements followed by WT and mutant p27 
with G418.  Expression of WT and mutant p27 was induced by ponasterone A (5 μM) for 
24, 48 and 72 hour followed by Western blot analysis.  (A) Induction of p27 WT protein 
was observed at 72 h in ACCh cells (upper panel).  Cell growth in wild type p27 
transfectant ACCh cells with or without ponasterone A (lower panel).  Each cells were 
cultured in the medium containing ponasterone A (5 μM), and then trypsinized cells were 
counted by Cell Counter at 0, 2, 4 and 6 day.  Bars, SD.  (B) Induction of p27 T187A 
mutant protein was observed at 24 h in ACCh cells (upper panel).  Cell growth in T187A 
mutant p27 transfectant ACCh cells with or without ponasterone A (lower panel).  Each 
cells were cultured in the medium containing ponasterone A (5 μM), and then trypsinized 
cells were counted by Cell Counter at 0, 2, 4 and 6 day.  Bars, SD.   
 
Fig. 2.  Immunohistochemical expression of Skp2 and p27 in ACC.  Representative case 
with high p27 expression (A) and low Skp2 expression (B) and case with low p27 
expression (C) and high Skp2 expression (D) are shown.     
 
Fig. 3.  Skp2 knockdown inhibits cell growth in ACC cells.  A. Expression of p27 and Skp2 
protein in control ACCh cells and Skp2 siRNA transfectant ACCh cells.  Cul1 expression 
is used as a loading control.  B. Cell proliferation of control ACCh cells and Skp2 siRNA 
transfectant ACCh cells.  5x103 cells were plated in 24 well plates and cells were counted 
at 0, 2, 4 and 6 day by using cell counter. 
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Table 1. Clinical data of ACC patients and immunohistochemical results 
Case No. Age Sex Site Grading Metastasis Skp2 expression p27 expression PCNA score
1 40 M PALATE II - - - I
2 76 M LOWER LIP II - - - II
3 60 F SM I - - - II
4 55 F SM I - - + I
5 78 F FOM I - - + I
6 65 F FOM I - - + I
7 81 F FOM I - - + I
8 74 F PALATE III + - + I
9 64 F SLG I + - + I
10 75 M PALATE I - - + I
11 57 F PAROTID II - - + II
12 49 F MAXILLA III - - + II
13 48 F RETROMORAL II + - + II
14 37 F FOM III + - + III
15 77 F TONGUE II - - ++ I
16 79 M PALATE II - - ++ I
17 76 M PALATE I - - ++ I
18 84 F FOM II - - ++ I
19 74 F SM I - - ++ I
20 49 F SM I - - ++ I
21 79 F SM II - - ++ I
22 74 M FOM I - - ++ I
23 46 F FOM I - - ++ II
24 79 M PALATE III - - ++ II
25 40 M PALATE II - - ++ II
26 78 M TONGUE I - - ++ II
27 65 M SM III - - ++ II
28 55 M PALATE III - - ++ II
29 30 M PAROTID I - - ++ II
30 63 F FOM II + - ++ II
31 61 M MAXILLA III - - ++ III
32 54 M MAXILLA III - - ++ III
33 45 F PALATE I - + - I
34 37 F FOM I - + - II
35 45 F REGION 7 I - + - II
36 48 M PALATE III - + - II
37 64 F PALATE II - + - II
38 52 F PALATE I - + - II
39 65 F MAXILLA II - + - III
40 39 M PAROTID I - + - III
41 30 F MAXILLA III + + - III
42 48 F SLG III - + + II
43 58 M PAROTID II - + + III
44 48 F TONGUE II - + + III
45 50 F PALATE III - + + III
46 73 M PALATE I - + ++ II
47 75 F FOM III - + ++ III
48 73 M MAXILLA III - + ++ III
49 43 M MAXILLA III - + ++ III
50 70 F SM III + + ++ III
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Table 2. Summary of Skp2 expression in ACC 
p27 
expression 
18 5 
11 4 0.00519 
3 9 
PCNA 
grading 
I 16 1 
II 13 7 0.000311 
III 3 10 
Histological 
grading 
I 14 6 
II 10 4 0.36624 
III 8 8 
Lymph 
node 
metastasis 
27 16 
0.6588 
5 2 
-
+ 
++ 
-
+ 
Skp2 expression 
+ - P value 
Total 32 18 
Total 
23 
15 
12 
17 
20 
13 
20 
14 
16 
43 
7 
50 



